WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007144358) USE OF ADIPOSE-TISSUE CELL FRACTIONS FOR POST-IRRADIATION TISSUE REGENERATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/144358    International Application No.:    PCT/EP2007/055782
Publication Date: 21.12.2007 International Filing Date: 12.06.2007
IPC:
A61K 45/00 (2006.01), A61P 17/02 (2006.01), A61P 43/00 (2006.01)
Applicants: INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE [FR/FR]; 77-83, avenue du Général de Gaulle, F-92140 Clamart (FR) (For All Designated States Except US).
TAMARAT, Radia [FR/FR]; (FR) (For US Only).
BENDERITTER, Marc [FR/FR]; (FR) (For US Only)
Inventors: TAMARAT, Radia; (FR).
BENDERITTER, Marc; (FR)
Agent: WARCOIN, AHNER, TEXIER, LE FORESTIER, CALLON DE LAMARCK, COLLIN, TETAZ; Cabinet Regimbeau, 20, rue de Chazelles, F-75847 Paris Cedex 17 (FR)
Priority Data:
0605190 12.06.2006 FR
Title (EN) USE OF ADIPOSE-TISSUE CELL FRACTIONS FOR POST-IRRADIATION TISSUE REGENERATION
(FR) UTILISATION DE FRACTIONS CELLULAIRES DU TISSU ADIPEUX POUR LA REGENERATION TISSULAIRE POST IRRADIATION
Abstract: front page image
(EN)The present invention concerns the use of cells derived from the cellular fraction of the vascular stroma of the extramedullary adipose tissue to promote the regeneration of tissue following lesions caused by irradiation. More specifically, the use according to the invention aims to prepare a drug for promoting regeneration of the skin, and in particular to repair the cutaneous wounds caused by irradiation.
(FR)La présente invention concerne l'utilisation de cellules issues de la fraction du stroma vasculaire du tissu adipeux extra médullaire, pour favoriser la régénération tissulaire à la suite de lésions causées par irradiation. Plus particulièrement l'utilisation selon l'invention est destinée à la préparation d'un médicament pour favoriser la régénération de la peau, notamment pour réparer les plaies cutanées causées par irradiation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)